Form 4: Charles River Labs Executive Birgit Girshick Reports Stock Transactions

Corporate Executive VP & COO of Charles River Laboratories, Birgit Girshick, reports acquisition of shares through performance share unit awards and disposition of shares to cover tax obligations.

Summary

• Birgit Girshick, Corporate Executive VP & COO of Charles River Laboratories, filed a Form 4.
• On January 31, 2025, Girshick acquired 4,057 shares of common stock related to performance share unit awards.
• These awards were originally granted on May 27, 2022, and vested upon achievement of performance goals.
• On the same day, Girshick disposed of 1,025 shares of common stock at a price of $165.57 per share.
• The disposition was likely to cover tax obligations related to the vesting of the performance share units.
• Following these transactions, Girshick beneficially owns 53,544 shares of Charles River Laboratories common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The acquisition of shares through performance awards is positive, but the sale of shares, even for tax purposes, can temper enthusiasm. Overall, it's a routine transaction.

Positives

• The acquisition of shares indicates confidence in the company's performance, as the shares were awarded based on the achievement of performance goals.

Negatives

• The sale of shares, while likely for tax purposes, could be perceived negatively by some investors.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.

Stakeholder Impact

• The transactions have a minor impact on shareholders, as they reflect insider activity related to compensation and tax obligations.

Key Dates